Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Restorbio

Request full access

Innovative medicines targeting aging biology to prevent or treat age-related diseases

Boston, United StatesFounded 2016Biotech & Life Sciences

About Restorbio

resTORbio is a biopharmaceutical company focused on developing innovative medicines that target the biology of aging to prevent or treat age-related diseases. The company operates in the healthcare and pharmaceutical market, primarily serving older adults who are at risk of or suffering from chronic diseases associated with aging. resTORbio's business model revolves around the discovery, development, and commercialization of drugs that modulate specific biochemical pathways, such as the TORC1 pathway, which are believed to regulate aging and its related diseases. The company generates revenue through the development and sale of these therapeutic drugs, as well as through partnerships and collaborations with other pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
57.0/100
Industry
Health, Jobs Recruitment
Sub-industry
Pharmaceutical, BioTechnology
Sector
Risk Management, Biotechnology, Biotech and Pharma, Silver Economy, Hard Tech, elderly care, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2017 $40M $160M Rock Springs Capital · OrbiMed · Quan Capital · Nest.Bio Labs —
SERIES AOther financing Jan 2017 $25M $100M PureTech —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Restorbio website traffic

Latest recorded traffic for Restorbio is 340 monthly website visits, down 49.3% over the last three months. Restorbio's team grew 0% over the past year.

Latest monthly visits340 3-month web change-49.3% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Restorbio in the Boston ecosystem

Live from Dealroom

The Restorbio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • PureTech
  • Rock Springs Capital
  • OrbiMed
  • Quan Capital
  • Nest.Bio Labs
  • Recharge Capital
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown

See Restorbio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.